Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cardiovascular Research|August 5, 2015
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMelvin Y Rincon, Thierry VandenDriessche, Marinee K ChuahJournal of Visualized Experiments : Jove|February 19, 2019
Production, Purification, and Quality Control for Adeno-associated Virus-based VectorsShelly Fripont, Catherine Marneffe, Marika Marino, et al.Seminars in Thrombosis and Hemostasis|June 3, 2026
Laboratory Monitoring of Complement Activation in Gene Therapy: Analytical Pitfalls and Clinical InterpretationBrandon Michael Henry, Melvin Y Rincon, Giuseppe Lippi, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
The role of the L-arginine-nitric oxide pathway in preeclampsiaPatricio López-Jaramillo, William D Arenas, Ronald G García, et al.JMIR Research Protocols|June 11, 2016
Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study ProtocolMelvin Y Rincon, Carlos E Prada, Marcos Lopez, et al.Oxidative Medicine and Cellular Longevity|April 21, 2020
Potential Role of Antioxidants as Adjunctive Therapy in Chagas DiseaseJuana P Sánchez-Villamil, Paula K Bautista-Niño, Norma C Serrano, et al.Medicina|December 13, 2019
[Immune response and gene therapy with adenoassociated viral vectors]Julieth A Sierra-Delgado, Paula K Bautista-Nino, Clara I Vargas-Castellanos, et al.Gene Therapy|March 11, 2018
Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vectorMelvin Y Rincon, Filip de Vin, Sandra I Duqué, et al.Folia Parasitologica|October 22, 2019
Measuring mitochondrial respiration in adherent cells infected with Trypanosoma cruzi Chagas, 1909 using Seahorse extracellular flux analyserLaura Maria Gonzalez-Ortiz, Juana Patricia Sanchez-Villamil, Mike A Celis-Rodriguez, et al.Blood|March 19, 2014
Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapyNisha Nair, Melvin Y Rincon, Hanneke Evens, et al.Pageof 2